Sources of extracellular, oxidatively-modified DNA lesions: implications for their measurement in urine.

PubWeight™: 0.98‹?› | Rank: Top 15%

🔗 View Article (PMC 2771246)

Published in J Clin Biochem Nutr on October 28, 2009

Authors

Marcus S Cooke1, Paul T Henderson, Mark D Evans

Author Affiliations

1: Radiation and Oxidative Stress Section, Department of Cancer Studies and Molecular Medicine, Robert Kilpatrick Clinical Sciences Bilding, University of Leicester, LE2 7LX, UK.

Articles citing this

8-Oxo-2'-deoxyguanosine as a biomarker of tobacco-smoking-induced oxidative stress. Free Radic Biol Med (2012) 0.92

Oxidative Stress and DNA Damage in Human Gastric Carcinoma: 8-Oxo-7'8-dihydro-2'-deoxyguanosine (8-oxo-dG) as a Possible Tumor Marker. Int J Mol Sci (2013) 0.90

Biomarkers of oxidative stress and its association with the urinary reducing capacity in bus maintenance workers. J Occup Med Toxicol (2011) 0.84

The biological and metabolic fates of endogenous DNA damage products. J Nucleic Acids (2010) 0.84

Salvage of oxidized guanine derivatives in the (2'-deoxy)ribonucleotide pool as source of mutations in DNA. Mutat Res (2010) 0.83

Oxidative damage and cellular defense mechanisms in sea urchin models of aging. Free Radic Biol Med (2013) 0.81

Oxidative stress, telomere shortening, and DNA methylation in relation to low-to-moderate occupational exposure to welding fumes. Environ Mol Mutagen (2015) 0.81

A beverage containing fermented black soybean ameliorates ferric nitrilotriacetate-induced renal oxidative damage in rats. J Clin Biochem Nutr (2010) 0.80

A novel method for efficient collection of normal mesothelial cells in vivo. J Clin Biochem Nutr (2010) 0.79

Associations between functional polymorphisms in antioxidant defense genes and urinary oxidative stress biomarkers in healthy, premenopausal women. Genes Nutr (2011) 0.77

Increase in oxidative stress levels following welding fume inhalation: a controlled human exposure study. Part Fibre Toxicol (2016) 0.76

One-year follow-up of clinical, metabolic and oxidative stress profile of morbid obese patients after laparoscopic sleeve gastrectomy. 8-oxo-dG as a clinical marker. Redox Biol (2017) 0.75

Fisetin Protects DNA Against Oxidative Damage and Its Possible Mechanism. Adv Pharm Bull (2016) 0.75

Articles cited by this

(truncated to the top 100)

Instability and decay of the primary structure of DNA. Nature (1993) 25.58

Molecular mechanisms of mammalian DNA repair and the DNA damage checkpoints. Annu Rev Biochem (2004) 14.93

Oxidative DNA damage: mechanisms, mutation, and disease. FASEB J (2003) 7.21

Oxidative damage to DNA during aging: 8-hydroxy-2'-deoxyguanosine in rat organ DNA and urine. Proc Natl Acad Sci U S A (1990) 4.06

Oxidative DNA damage and disease: induction, repair and significance. Mutat Res (2004) 3.54

Mammalian deoxyribonucleoside kinases. Pharmacol Ther (1995) 3.31

Urinary 8-hydroxy-2'-deoxyguanosine as a biological marker of in vivo oxidative DNA damage. Proc Natl Acad Sci U S A (1989) 2.92

RNA oxidation is a prominent feature of vulnerable neurons in Alzheimer's disease. J Neurosci (1999) 2.86

Thymine glycol and thymidine glycol in human and rat urine: a possible assay for oxidative DNA damage. Proc Natl Acad Sci U S A (1984) 2.82

Cloning and characterization of a mammalian 8-oxoguanine DNA glycosylase. Proc Natl Acad Sci U S A (1997) 2.74

Repair of oxidized bases in DNA bubble structures by human DNA glycosylases NEIL1 and NEIL2. J Biol Chem (2003) 2.53

In vitro repair of oxidative DNA damage by human nucleotide excision repair system: possible explanation for neurodegeneration in xeroderma pigmentosum patients. Proc Natl Acad Sci U S A (1997) 2.44

Parkinson's disease is associated with oxidative damage to cytoplasmic DNA and RNA in substantia nigra neurons. Am J Pathol (1999) 2.31

Oxidative DNA damage estimated by 8-hydroxydeoxyguanosine excretion in humans: influence of smoking, gender and body mass index. Carcinogenesis (1992) 2.31

DNA precursor metabolism and genomic stability. FASEB J (2006) 2.25

Hydrolytic elimination of a mutagenic nucleotide, 8-oxodGTP, by human 18-kilodalton protein: sanitization of nucleotide pool. Proc Natl Acad Sci U S A (1992) 2.04

Establishing the background level of base oxidation in human lymphocyte DNA: results of an interlaboratory validation study. FASEB J (2004) 2.01

DNA oxidation matters: the HPLC-electrochemical detection assay of 8-oxo-deoxyguanosine and 8-oxo-guanine. Proc Natl Acad Sci U S A (1998) 2.01

Human DNA glycosylases of the bacterial Fpg/MutM superfamily: an alternative pathway for the repair of 8-oxoguanine and other oxidation products in DNA. Nucleic Acids Res (2002) 1.96

Chemical determination of free radical-induced damage to DNA. Free Radic Biol Med (1991) 1.89

Assay of excised oxidative DNA lesions: isolation of 8-oxoguanine and its nucleoside derivatives from biological fluids with a monoclonal antibody column. Proc Natl Acad Sci U S A (1992) 1.76

Evidence for two DNA repair enzymes for 8-hydroxyguanine (7,8-dihydro-8-oxoguanine) in human cells. J Biol Chem (1993) 1.71

Cloning of a human homolog of the yeast OGG1 gene that is involved in the repair of oxidative DNA damage. Oncogene (1997) 1.69

Oxidized messenger RNA induces translation errors. Proc Natl Acad Sci U S A (2006) 1.59

Factors contributing to the outcome of oxidative damage to nucleic acids. Bioessays (2004) 1.55

The mammalian mismatch repair pathway removes DNA 8-oxodGMP incorporated from the oxidized dNTP pool. Curr Biol (2002) 1.53

Repair pathways for processing of 8-oxoguanine in DNA by mammalian cell extracts. J Biol Chem (1998) 1.52

The type of DNA glycosylase determines the base excision repair pathway in mammalian cells. J Biol Chem (1999) 1.51

Messenger RNA oxidation is an early event preceding cell death and causes reduced protein expression. FASEB J (2007) 1.49

Foreign (M13) DNA ingested by mice reaches peripheral leukocytes, spleen, and liver via the intestinal wall mucosa and can be covalently linked to mouse DNA. Proc Natl Acad Sci U S A (1997) 1.43

Excision of damaged thymine residues from gamma-irradiated poly(dA-dT) by crude extracts of Escherichia coli. Proc Natl Acad Sci U S A (1974) 1.36

Systemic increase of oxidative nucleic acid damage in Parkinson's disease and multiple system atrophy. Neurobiol Dis (2002) 1.34

Phosphorylation of nucleosides and nucleoside analogs by mammalian nucleoside monophosphate kinases. Pharmacol Ther (2000) 1.32

Urinary 8-hydroxydeoxyguanosine and its analogs as DNA marker of oxidative stress: development of an ELISA and measurement in both bladder and prostate cancers. Clin Chim Acta (2003) 1.32

Biomarker evidence of DNA oxidation in lung cancer patients: association of urinary 8-hydroxy-2'-deoxyguanosine excretion with radiotherapy, chemotherapy, and response to treatment. FEBS Lett (1997) 1.29

Incorporation and replication of 8-oxo-deoxyguanosine by the human mitochondrial DNA polymerase. J Biol Chem (2006) 1.29

Redox ribonucleosides. Isolation and characterization of 5-hydroxyuridine, 8-hydroxyguanosine, and 8-hydroxyadenosine from Torula yeast RNA. J Biol Chem (1992) 1.28

DNA replication fidelity with 8-oxodeoxyguanosine triphosphate. Biochemistry (1994) 1.28

Selective expansion of mitochondrial nucleoside triphosphate pools in antimetabolite-treated HeLa cells. J Biol Chem (1982) 1.28

Does measurement of oxidative damage to DNA have clinical significance? Clin Chim Acta (2005) 1.27

Steady-state and pre-steady-state kinetic analysis of 8-oxo-7,8-dihydroguanosine triphosphate incorporation and extension by replicative and repair DNA polymerases. Biochemistry (1998) 1.26

Quantification of 8-oxo-guanine and guanine as the nucleobase, nucleoside and deoxynucleoside forms in human urine by high-performance liquid chromatography-electrospray tandem mass spectrometry. Nucleic Acids Res (2002) 1.24

A carbon column-based liquid chromatography electrochemical approach to routine 8-hydroxy-2'-deoxyguanosine measurements in urine and other biologic matrices: a one-year evaluation of methods. Free Radic Biol Med (1999) 1.23

Mutagenesis by apurinic sites in normal and ataxia telangiectasia human lymphoblastoid cells. Mol Carcinog (1992) 1.23

Etheno DNA-base adducts from endogenous reactive species. Mutat Res (1999) 1.22

NEIL1 excises 3' end proximal oxidative DNA lesions resistant to cleavage by NTH1 and OGG1. Nucleic Acids Res (2005) 1.20

DNA repair is responsible for the presence of oxidatively damaged DNA lesions in urine. Mutat Res (2005) 1.18

APE1-dependent repair of DNA single-strand breaks containing 3'-end 8-oxoguanine. Nucleic Acids Res (2005) 1.16

Single-turnover kinetic analysis of the mutagenic potential of 8-oxo-7,8-dihydro-2'-deoxyguanosine during gap-filling synthesis catalyzed by human DNA polymerases lambda and beta. J Mol Biol (2007) 1.14

The 3'->5' exonuclease of Apn1 provides an alternative pathway to repair 7,8-dihydro-8-oxodeoxyguanosine in Saccharomyces cerevisiae. Mol Cell Biol (2005) 1.14

A novel mechanism for preventing mutations caused by oxidation of guanine nucleotides. EMBO Rep (2003) 1.14

Hydrogen peroxide in human urine: implications for antioxidant defense and redox regulation. Biochem Biophys Res Commun (1999) 1.14

Quantitative analysis of the oxidative DNA lesion, 2,2-diamino-4-(2-deoxy-beta-D-erythro-pentofuranosyl)amino]-5(2H)-oxazolone (oxazolone), in vitro and in vivo by isotope dilution-capillary HPLC-ESI-MS/MS. Nucleic Acids Res (2006) 1.13

Incorporation of the guanosine triphosphate analogs 8-oxo-dGTP and 8-NH2-dGTP by reverse transcriptases and mammalian DNA polymerases. J Biol Chem (1997) 1.13

Mouse MTH2 protein which prevents mutations caused by 8-oxoguanine nucleotides. Biochem Biophys Res Commun (2003) 1.13

Different DNA repair strategies to combat the threat from 8-oxoguanine. Mutat Res (2007) 1.12

Prospective study of 8-oxo-7,8-dihydro-2'-deoxyguanosine excretion and the risk of lung cancer. Carcinogenesis (2005) 1.11

On the fate of orally ingested foreign DNA in mice: chromosomal association and placental transmission to the fetus. Mol Gen Genet (1998) 1.09

Repair and replication of plasmids with site-specific 8-oxodG and 8-AAFdG residues in normal and repair-deficient human cells. Nucleic Acids Res (1992) 1.08

Dissection of the molecular defects caused by pathogenic mutations in the DNA repair factor XPC. Mol Cell Biol (2008) 1.06

Detection of periodontopathic bacteria and an oxidative stress marker in saliva from periodontitis patients. Oral Microbiol Immunol (2005) 1.06

In vivo oxidative DNA damage: measurement of 8-hydroxy-2'-deoxyguanosine in DNA and urine by high-performance liquid chromatography with electrochemical detection. Methods Enzymol (1990) 1.06

The nucleotide pool is a significant target for oxidative stress. Free Radic Biol Med (2006) 1.05

Peroxynitrite-induced reactions of synthetic oligonucleotides containing 8-oxoguanine. Chem Res Toxicol (1999) 1.05

Measurement of the malondialdehyde-2'-deoxyguanosine adduct in human urine by immuno-extraction and liquid chromatography/atmospheric pressure chemical ionization tandem mass spectrometry. J Mass Spectrom (2004) 1.05

Increased urinary excretion of 8-oxo-2'-deoxyguanosine, a biomarker of oxidative DNA damage, in urban bus drivers. Mutat Res (1999) 1.04

A quantitative model of human DNA base excision repair. I. Mechanistic insights. Nucleic Acids Res (2002) 1.04

Urinary excretion of three nucleic acid oxidation adducts and isoprostane F(2)alpha measured by liquid chromatography-mass spectrometry in smokers, ex-smokers, and nonsmokers. Free Radic Biol Med (2003) 1.04

In vivo oxidative metabolism of a major peroxidation-derived DNA adduct, M1dG. Proc Natl Acad Sci U S A (2006) 1.04

A high-throughput and sensitive methodology for the quantification of urinary 8-hydroxy-2'-deoxyguanosine: measurement with gas chromatography-mass spectrometry after single solid-phase extraction. Biochem J (2004) 1.03

Metabolic processing of cyclobutyl pyrimidine dimers and (6-4) photoproducts in UV-treated human cells. Evidence for distinct excision-repair pathways. J Biol Chem (1994) 1.03

Reconstitution of the base excision repair pathway for 7,8-dihydro-8-oxoguanine with purified human proteins. Nucleic Acids Res (2002) 1.03

Generation and elimination of 8-oxo-7,8-dihydro-2'-deoxyguanosine 5'-triphosphate, a mutagenic substrate for DNA synthesis, in human cells. Biochemistry (1995) 1.02

8-oxoguanine incorporation into DNA repeats in vitro and mismatch recognition by MutSalpha. Nucleic Acids Res (2005) 1.01

In vivo release from a drug delivery MEMS device. J Control Release (2004) 1.01

Patterns of urinary excretion of modified nucleosides. Cancer Res (1979) 1.01

Human polynucleotide phosphorylase protein in response to oxidative stress. Biochemistry (2006) 1.00

Evaluation of microdosing strategies for studies in preclinical drug development: demonstration of linear pharmacokinetics in dogs of a nucleoside analog over a 50-fold dose range. Drug Metab Dispos (2004) 0.98

Characterization of oxaliplatin-DNA adduct formation in DNA and differentiation of cancer cell drug sensitivity at microdose concentrations. Chem Res Toxicol (2007) 0.98

Severe oxidatively damaged DNA after cisplatin treatment of cancer patients. Int J Cancer (2006) 0.98

The highest levels of purine catabolic enzymes in mice are present in the proximal small intestine. J Biol Chem (1993) 0.97

Measurement of 7,8-dihydro-8-oxo-2'-deoxyguanosine metabolism in MCF-7 cells at low concentrations using accelerator mass spectrometry. Proc Natl Acad Sci U S A (2007) 0.97

Oxidative DNA damage: biological significance and methods of analysis. Crit Rev Clin Lab Sci (2002) 0.97

Competitive reactions of peroxynitrite with 2'-deoxyguanosine and 7,8-dihydro-8-oxo-2'-deoxyguanosine (8-oxodG): relevance to the formation of 8-oxodG in DNA exposed to peroxynitrite. Free Radic Biol Med (1996) 0.94

The dynamics of folic acid metabolism in an adult given a small tracer dose of 14C-folic acid. Adv Exp Med Biol (1998) 0.93

Detection of Adriamycin-DNA adducts by accelerator mass spectrometry at clinically relevant Adriamycin concentrations. Nucleic Acids Res (2008) 0.93

Measurement of 8-oxo-2'-deoxyguanosine and 8-oxo-2'-deoxyadenosine in DNA and human urine by high performance liquid chromatography-electrospray tandem mass spectrometry. Free Radic Biol Med (2001) 0.93

A new automated method to analyze urinary 8-hydroxydeoxyguanosine by a high-performance liquid chromatography-electrochemical detector system. J Radiat Res (2003) 0.93

Simultaneous determination of five oxidative DNA lesions in human urine. Chem Res Toxicol (1999) 0.93

Evaluation of enzyme-linked immunosorbent assay and liquid chromatography-tandem mass spectrometry methodology for the analysis of 8-oxo-7,8-dihydro-2'-deoxyguanosine in saliva and urine. Free Radic Biol Med (2006) 0.92

Increased urinary excretion of the oxidative DNA adduct, 8-hydroxydeoxyguanosine, as a possible early indicator of occupational cancer hazards in the asbestos, rubber, and azo-dye industries. Pol J Occup Med Environ Health (1993) 0.92

Comparative repair of the endogenous lesions 8-oxo-7, 8-dihydroguanine (8-oxoG), uracil and abasic site by mammalian cell extracts: 8-oxoG is poorly repaired by human cell extracts. Carcinogenesis (2000) 0.91

Extracellular 8-oxo-dG as a sensitive parameter for oxidative stress in vivo and in vitro. Free Radic Res (2005) 0.91

8-Hydroxydeoxyguanosine in leukocyte DNA and urine of quartz-exposed workers and patients with silicosis. Int Arch Occup Environ Health (2000) 0.90

Urinary 8-oxo-7,8-dihydro-2'-deoxyguanosine values measured by an ELISA correlated well with measurements by high-performance liquid chromatography with electrochemical detection. Cancer Epidemiol Biomarkers Prev (2002) 0.90

Metabolism in vitro and in vivo of the DNA base adduct, M1G. Chem Res Toxicol (2007) 0.89

Exercise, oxidative damage and effects of antioxidant manipulation. J Nutr (1992) 0.89

Cyclobutane thymidine dimers are present in human urine following sun exposure: quantitation using 32P-postlabeling and high-performance liquid chromatography. J Invest Dermatol (2001) 0.89

Leukemic cell line, KG-1 has a functional loss of hOGG1 enzyme due to a point mutation and 8-hydroxydeoxyguanosine can kill KG-1. Oncogene (2000) 0.89

Analysis of urinary 8-oxo-7,8-dihydro-purine-2'-deoxyribonucleosides by LC-MS/MS and improved ELISA. Free Radic Res (2008) 0.88

Articles by these authors

Oxidative DNA damage: mechanisms, mutation, and disease. FASEB J (2003) 7.21

Plasma anandamide concentration and pregnancy outcome in women with threatened miscarriage. JAMA (2008) 1.60

The aflatoxin B(1) formamidopyrimidine adduct plays a major role in causing the types of mutations observed in human hepatocellular carcinoma. Proc Natl Acad Sci U S A (2002) 1.41

High-fidelity in vivo replication of DNA base shape mimics without Watson-Crick hydrogen bonds. Proc Natl Acad Sci U S A (2003) 1.32

Does measurement of oxidative damage to DNA have clinical significance? Clin Chim Acta (2005) 1.27

DNA repair is responsible for the presence of oxidatively damaged DNA lesions in urine. Mutat Res (2005) 1.18

Kinetics of carboplatin-DNA binding in genomic DNA and bladder cancer cells as determined by accelerator mass spectrometry. Chem Res Toxicol (2006) 1.14

Different apolipoproteins impact nanolipoprotein particle formation. J Am Chem Soc (2007) 1.06

Combination of azathioprine and UVA irradiation is a major source of cellular 8-oxo-7,8-dihydro-2'-deoxyguanosine. DNA Repair (Amst) (2008) 1.04

Urinary 8-oxo-2'-deoxyguanosine: redox regulation of DNA repair in vivo? Free Radic Biol Med (2002) 1.04

Toward consensus in the analysis of urinary 8-oxo-7,8-dihydro-2'-deoxyguanosine as a noninvasive biomarker of oxidative stress. FASEB J (2009) 1.02

In vivo release from a drug delivery MEMS device. J Control Release (2004) 1.01

Evaluation of microdosing strategies for studies in preclinical drug development: demonstration of linear pharmacokinetics in dogs of a nucleoside analog over a 50-fold dose range. Drug Metab Dispos (2004) 0.98

Characterization of oxaliplatin-DNA adduct formation in DNA and differentiation of cancer cell drug sensitivity at microdose concentrations. Chem Res Toxicol (2007) 0.98

Biologically relevant oxidants and terminology, classification and nomenclature of oxidatively generated damage to nucleobases and 2-deoxyribose in nucleic acids. Free Radic Res (2012) 0.97

Measurement of 7,8-dihydro-8-oxo-2'-deoxyguanosine metabolism in MCF-7 cells at low concentrations using accelerator mass spectrometry. Proc Natl Acad Sci U S A (2007) 0.97

Plasma levels of the endocannabinoid anandamide in women--a potential role in pregnancy maintenance and labor? J Clin Endocrinol Metab (2004) 0.97

Characterizing diffusion dynamics of a membrane protein associated with nanolipoproteins using fluorescence correlation spectroscopy. Protein Sci (2011) 0.97

Hydrogen production by a hyperthermophilic membrane-bound hydrogenase in water-soluble nanolipoprotein particles. J Am Chem Soc (2009) 0.95

Human and methodological sources of variability in the measurement of urinary 8-oxo-7,8-dihydro-2'-deoxyguanosine. Antioxid Redox Signal (2013) 0.94

Rapid measurement of 8-oxo-7,8-dihydro-2'-deoxyguanosine in human biological matrices using ultra-high-performance liquid chromatography-tandem mass spectrometry. Free Radic Biol Med (2012) 0.94

Cell-free expression for nanolipoprotein particles: building a high-throughput membrane protein solubility platform. Methods Mol Biol (2009) 0.93

Detection of Adriamycin-DNA adducts by accelerator mass spectrometry at clinically relevant Adriamycin concentrations. Nucleic Acids Res (2008) 0.93

Hydantoin derivative formation from oxidation of 7,8-dihydro-8-oxo-2'-deoxyguanosine (8-oxodG) and incorporation of 14C-labeled 8-oxodG into the DNA of human breast cancer cells. Bioorg Med Chem Lett (2005) 0.93

Evaluation of enzyme-linked immunosorbent assay and liquid chromatography-tandem mass spectrometry methodology for the analysis of 8-oxo-7,8-dihydro-2'-deoxyguanosine in saliva and urine. Free Radic Biol Med (2006) 0.92

Personalized medicine for targeted and platinum-based chemotherapy of lung and bladder cancer. Bioanalysis (2013) 0.88

Human microdosing for the prediction of patient response. Bioanalysis (2010) 0.87

In vivo bypass efficiencies and mutational signatures of the guanine oxidation products 2-aminoimidazolone and 5-guanidino-4-nitroimidazole. J Biol Chem (2004) 0.86

Simplified method for the collection, storage, and comet assay analysis of DNA damage in whole blood. Free Radic Biol Med (2011) 0.86

8-Oxo-deoxyguanosine: reduce, reuse, recycle? Proc Natl Acad Sci U S A (2007) 0.86

Biodistribution and pharmacokinetics of a telodendrimer micellar paclitaxel nanoformulation in a mouse xenograft model of ovarian cancer. Int J Nanomedicine (2012) 0.86

The alternative splice variant of protein tyrosine kinase 6 negatively regulates growth and enhances PTK6-mediated inhibition of β-catenin. PLoS One (2011) 0.86

Recent advances in biomedical applications of accelerator mass spectrometry. J Biomed Sci (2009) 0.84

Progress in the analysis of urinary oxidative DNA damage. Free Radic Biol Med (2002) 0.84

Incorporation of extracellular 8-oxodG into DNA and RNA requires purine nucleoside phosphorylase in MCF-7 cells. Nucleic Acids Res (2007) 0.84

Characterization of high-affinity peptides and their feasibility for use in nanotherapeutics targeting leukemia stem cells. Nanomedicine (2011) 0.83

Salvage of oxidized guanine derivatives in the (2'-deoxy)ribonucleotide pool as source of mutations in DNA. Mutat Res (2010) 0.83

Recommendations for standardized description of and nomenclature concerning oxidatively damaged nucleobases in DNA. Chem Res Toxicol (2010) 0.82

DNA repair: insights from urinary lesion analysis. Free Radic Res (2002) 0.81

Interlaboratory comparison of methodologies for the measurement of urinary 8-oxo-7,8-dihydro-2'-deoxyguanosine. Biomarkers (2009) 0.81

Efficient synthesis of DNA containing the guanine oxidation-nitration product 5-guanidino-4-nitroimidazole: generation by a postsynthetic substitution reaction. Org Lett (2004) 0.81

Controlling the diameter, monodispersity, and solubility of ApoA1 nanolipoprotein particles using telodendrimer chemistry. Protein Sci (2013) 0.80

Cutaneous sinus tracts of dental origin. Med J Aust (2007) 0.80

Non-invasive assessment of oxidatively damaged DNA: liquid chromatography-tandem mass spectrometry analysis of urinary 8-oxo-7,8-dihydro-2'-deoxyguanosine. Methods Mol Biol (2011) 0.79

Towards biomarker-dependent individualized chemotherapy: exploring cell-specific differences in oxaliplatin-DNA adduct distribution using accelerator mass spectrometry. Bioorg Med Chem Lett (2010) 0.79

Evidence for attenuated cellular 8-oxo-7,8-dihydro-2'-deoxyguanosine removal in cancer patients. Biol Chem (2006) 0.79

Deoxycytidine glyoxal: lesion induction and evidence of repair following vitamin C supplementation in vivo. Free Radic Biol Med (2003) 0.78

Immuno-slot blot assay for detection of UVR-mediated DNA damage. Methods Mol Biol (2012) 0.78

Detection of adriamycin-DNA adducts by accelerator mass spectrometry. Methods Mol Biol (2010) 0.77

Immunochemical detection of UV-induced DNA damage and repair. J Immunol Methods (2003) 0.77

Associations between functional polymorphisms in antioxidant defense genes and urinary oxidative stress biomarkers in healthy, premenopausal women. Genes Nutr (2011) 0.77

Antiserum detection of reactive carbonyl species-modified DNA in human colonocytes. Free Radic Res (2008) 0.76

Quantification of UVR-induced DNA damage: global- versus gene-specific levels of thymine dimers. J Immunol Methods (2003) 0.76

Nanomicelle formulation modifies the pharmacokinetic profiles and cardiac toxicity of daunorubicin. Nanomedicine (Lond) (2014) 0.75

Evidence that oxidative stress is a risk factor for the development of squamous cell carcinoma in renal transplant patients. Free Radic Biol Med (2007) 0.75